Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akari, Astrazeneca, Glaxosmithkline, Mereo, Orpheris, Ovid, Redhill, Takeda, Union, Vir.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Arrowhead, Assembly, Daiichi Sankyo, Enanta, Fortress, Idorsia, Janssen, Matinas, Treadwell, Viking.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Carl Zeiss Meditech, Eurofins, Tandem Diabetes Care.